/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Avanir Pharmaceuticals Inc\n \n\n\n\n\n
Nov 22 12:06 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 17, 2009 8:30 AM EST
\n\n \n AVANIR Pharmaceuticals Invites Investors to Fourth Quarter and Fiscal Year End Conference Call - Business Wire\n \n \n
\n\n Nov 13, 2009 6:49 AM EST
\n\n \n RothmanResearch.com Completes Analysis on KSU, PCLN, NUVA, PWAV, AVNR and WCRX - Marketwire\n \n \n
\n\n Nov 11, 2009 8:30 AM EST
\n\n \n AVANIR to Present at the Lazard Healthcare Conference - Business Wire\n \n \n
\n\n Nov 10, 2009 8:30 AM EST
\n\n \n Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy Data from Star Trial Open Label Extension - Business Wire\n \n \n
\n\n Nov 04, 2009 5:34 AM EST
\n\n \n AnalystChoice.com Gives Technical review on ARTG, BEAV, NUVA, ACAS, CEDC and AVNR - Marketwire\n \n \n
\n\n Nov 03, 2009 6:51 AM EST
\n\n \n Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com - GlobeNewswire\n \n \n
\n\n Oct 26, 2009 7:10 AM EDT
\n\n \n WallStSense.com Offers Detailed Analysis on DWA, SVNT, ATVI, SSRI, CIEN and AVNR - Marketwire\n \n \n
\n
\n\n");